The safety profile of single antiplatelet therapy with flow diverters: Systematic review and meta-analysis.
Yigit Can SenolAtakan OrscelikSherief A GhozyKobeissi HassanSanthosh ArulCem BilginRamanathan D KadirvelDavid F KallmesPublished in: Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences (2023)
Flow diverter treatment under ASA monotherapy resulted in relatively high ischemic complication rates. However, SAPT with prasugrel or ticagrelor monotherapy is promising for coated FDs and ruptured aneurysm treatments. Given the overall small sample size and also the likely presence of known and unknown biases regarding choice of antiplatelet therapy between groups, larger cohort studies are needed to evaluate SAPT treatment outcomes.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- combination therapy
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- coronary artery disease
- coronary artery
- open label
- abdominal aortic aneurysm
- internal carotid artery
- subarachnoid hemorrhage
- ischemia reperfusion injury
- randomized controlled trial
- clinical trial
- brain injury
- study protocol